Table 2.
Measurements of the enhancing target tumors by CEUS and CT/MRI
| CEUS | CT/MRI | P | |
|---|---|---|---|
| Sum of LDETT (mm) | |||
| Baseline | 86.8±47.8 (41–271) | 84.1±47.0 (35–271) | 0.034 |
| One month after the third TACE | 57.0±53.4 (0–263) | 57.8±56.7 (0–268) | 0.679 |
| Degree of necrosis (%) | 40.9±36.0 (−21.1a–100) | 38.4±36.9 (−20a–100) | 0.4 |
a
Negative values indicate an increase rather than a decrease in the enhancing tumor after TACE.
CEUS, contrast-enhanced ultrasonography; CT/MRI, computed tomography/magnetic resonance imaging; LDETT, longest diameter of the enhancing target tumor; TACE, transarterial chemoembolization.